Cargando…

Aspects of Innate Immunity and Parkinson’s Disease

Genetic studies on PARK genes have identified dysfunction in proteasomal, lysosomal, and mitochondrial enzymes as pathogenic for Parkinson’s disease (PD). We review the role of these and similar enzymes in mediating innate immune signaling. In particular, we have identified that a number of PARK gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yue, Halliday, Glenda M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296959/ https://www.ncbi.nlm.nih.gov/pubmed/22408621 http://dx.doi.org/10.3389/fphar.2012.00033

Ejemplares similares

Heme on innate immunity and inflammation
por: Dutra, Fabianno F., et al.
Publicado: (2014)

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
por: Dzamko, Nicolas, et al.
Publicado: (2014)

The Role of the Innate Immune System in ALS
por: Phani, Sudarshan, et al.
Publicado: (2012)

History of Innate Immunity in Neurodegenerative Disorders
por: McGeer, Patrick L., et al.
Publicado: (2011)

Adrenergic regulation of innate immunity: a review
por: Scanzano, Angela, et al.
Publicado: (2015)

Innate Immunity at the Core of Sex Differences in Osteoarthritic Pain?
por: Valdrighi, Natália, et al.
Publicado: (2022)

Innate Immunity in Diabetic Wound Healing: Focus on the Mastermind Hidden in Chronic Inflammatory
por: Geng, Kang, et al.
Publicado: (2021)

The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases
por: Huang, Boyuan, et al.
Publicado: (2022)

Aspects of innate immunity in Sjögren's syndrome
por: Low, Hui Zhi, et al.
Publicado: (2011)

Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis
por: Chen, Li, et al.
Publicado: (2022)

Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
por: Huang, Yue, et al.
Publicado: (2012)

Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection
por: Farooq, Mariya, et al.
Publicado: (2022)

Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment
por: Attiq, Ali, et al.
Publicado: (2023)

Periphery and brain, innate and adaptive immunity in Parkinson’s disease
por: Harms, Ashley S., et al.
Publicado: (2021)

The Noradrenergic System in Parkinson’s Disease
por: Paredes-Rodriguez, Elena, et al.
Publicado: (2020)

Effects of heme oxygenase-1 on innate and adaptive immune responses promoting pregnancy success and allograft tolerance
por: Schumacher, Anne, et al.
Publicado: (2015)

No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation
por: Hu, Rong, et al.
Publicado: (2020)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease
por: Hooshmand, Kosar, et al.
Publicado: (2022)

Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases
por: Gagliano, Sarah A., et al.
Publicado: (2016)

A Critical Review of Zebrafish Models of Parkinson’s Disease
por: Doyle, Jillian M., et al.
Publicado: (2022)

LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
por: Guerreiro, Patrícia Silva, et al.
Publicado: (2012)

Advances in non-dopaminergic treatments for Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
por: Miguelez, Cristina, et al.
Publicado: (2020)

Sleep Disorders in Rodent Models of Parkinson’s Disease
por: Medeiros, Daniel de Castro, et al.
Publicado: (2019)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
por: Gómez-Benito, Mónica, et al.
Publicado: (2020)

Parkinson’s disease, dopaminergic drugs and the plant world
por: Kempster, Peter, et al.
Publicado: (2022)

Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
por: Huang, Junqi, et al.
Publicado: (2022)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

GYF-21, an Epoxide 2-(2-Phenethyl)-Chromone Derivative, Suppresses Innate and Adaptive Immunity via Inhibiting STAT1/3 and NF-κB Signaling Pathways
por: Guo, Ran, et al.
Publicado: (2017)

FGF, Mechanism of Action, Role in Parkinson’s Disease, and Therapeutics
por: Liu, Yiqiu, et al.
Publicado: (2021)

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
por: Pérez-Lloret, Santiago, et al.
Publicado: (2021)

Nitric Oxide Involvement in Cardiovascular Dysfunctions of Parkinson Disease
por: Martins-Pinge, Marli Cardoso, et al.
Publicado: (2022)

Immunomodulatory Activity of Diterpenes over Innate Immunity and Cytokine Production in a Human Alveolar Epithelial Cell Line Infected with Mycobacterium tuberculosis
por: Hernández-Herrera, Alejandro David, et al.
Publicado: (2023)

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
por: Li, Wen, et al.
Publicado: (2021)

Understanding the role of "sunshine vitamin D" in Parkinson’s disease: A review
por: Behl, Tapan, et al.
Publicado: (2022)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

An Overview of Systematic Reviews of Chinese Herbal Medicine for Parkinson's Disease
por: Jin, Xin-Chun, et al.
Publicado: (2019)

Role of Nrf2 in Parkinson’s Disease: Toward New Perspectives
por: Yang, Xin-xing, et al.
Publicado: (2022)

Drug reprofiling history and potential therapies against Parkinson’s disease
por: Latif, Komal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r9csg5qa21ijalu8552lkcvmdk